Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2002-10-17
pubmed:abstractText
We aimed to clarify the relation between sarpogrelate (SG), a 5-hydroxytryptamine (5-HT)-2 receptor blocker, and myocardial interstitial serotonin or infarct size during ischemia and reperfusion.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/5-hydroxydecanoic acid, http://linkedlifedata.com/resource/pubmed/chemical/Adenosine Triphosphate, http://linkedlifedata.com/resource/pubmed/chemical/Alkaloids, http://linkedlifedata.com/resource/pubmed/chemical/Benzophenanthridines, http://linkedlifedata.com/resource/pubmed/chemical/Decanoic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxy Acids, http://linkedlifedata.com/resource/pubmed/chemical/Isoenzymes, http://linkedlifedata.com/resource/pubmed/chemical/Phenanthridines, http://linkedlifedata.com/resource/pubmed/chemical/Potassium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C-epsilon, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Serotonin, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin, http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Succinates, http://linkedlifedata.com/resource/pubmed/chemical/chelerythrine, http://linkedlifedata.com/resource/pubmed/chemical/sarpogrelate
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0735-1097
pubmed:author
pubmed:issnType
Print
pubmed:day
2
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1347-55
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:12383585-Adenosine Triphosphate, pubmed-meshheading:12383585-Alkaloids, pubmed-meshheading:12383585-Animals, pubmed-meshheading:12383585-Benzophenanthridines, pubmed-meshheading:12383585-Decanoic Acids, pubmed-meshheading:12383585-Disease Models, Animal, pubmed-meshheading:12383585-Drug Evaluation, Preclinical, pubmed-meshheading:12383585-Hemodynamics, pubmed-meshheading:12383585-Hydroxy Acids, pubmed-meshheading:12383585-Isoenzymes, pubmed-meshheading:12383585-Myocardial Infarction, pubmed-meshheading:12383585-Phenanthridines, pubmed-meshheading:12383585-Potassium Channel Blockers, pubmed-meshheading:12383585-Protein Kinase C, pubmed-meshheading:12383585-Protein Kinase C-epsilon, pubmed-meshheading:12383585-Rabbits, pubmed-meshheading:12383585-Receptors, Serotonin, pubmed-meshheading:12383585-Serotonin, pubmed-meshheading:12383585-Serotonin Antagonists, pubmed-meshheading:12383585-Succinates
pubmed:year
2002
pubmed:articleTitle
The role of serotonin in ischemic cellular damage and the infarct size-reducing effect of sarpogrelate, a 5-hydroxytryptamine-2 receptor blocker, in rabbit hearts.
pubmed:affiliation
Second Department of Internal Medicine, Gifu University School of Medicine, Gifu, Japan.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't